Researchers at Johns Hopkins Medicine have developed a new blood test that could help detect liver disease years before ...

WASHINGTON -- An investigational multi-target blood test was three times more sensitive than standard ultrasound surveillance for detecting early hepatocellular carcinoma (HCC), according to a ...

Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S.

Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...

The US FDA has approved Wako Diagnostics’s new LBA AFP-L3 test system. It is intended for the risk assessment of developing hepatocellular carcinoma (HCC), liver cancer in patients with chronic liver ...

This retrospective analysis examined real-world data from ctDNA testing on 125 patients with HCC (721 plasma samples) undergoing curative-intent treatments and SOC management. Patients were divided ...

Cancer Burden in Bangladesh: Insights From National Institute of Cancer Research & Hospital, 2014-2020 Hepatocellular carcinoma (HCC) is a major cause of cancer mortality in sub-Saharan Africa, with ...